CTI-1601

· Larimar Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CTI-1601, covering 2024-11-29 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia [Phase 2]